With ASH abstracts released on 11/7, I am wondering what investors are expecting or even hoping to see? Do you think INFI will have a good showing at ASH?
buying more later at lower PPS
Bump. Anyone have an opinion?
An update on the ongoing Phase I in B and T cell lymphomas---continued strong and rapid efficacy signals and better safety data than was presented at ASCO.